Native T1 Mapping in Differentiation of Normal Myocardium From Diffuse Disease in Hypertrophic and Dilated Cardiomyopathy

Department of Cardiovascular Imaging, King's College London, London, United Kingdom.
JACC. Cardiovascular imaging (Impact Factor: 7.19). 03/2013; 6(4). DOI: 10.1016/j.jcmg.2012.08.019
Source: PubMed


OBJECTIVES: The aim of this study was to examine the value of native and post-contrast T1 relaxation in the differentiation between healthy and diffusely diseased myocardium in 2 model conditions, hypertrophic cardiomyopathy and nonischemic dilated cardiomyopathy. BACKGROUND: T1 mapping has been proposed as potentially valuable in the quantitative assessment of diffuse myocardial fibrosis, but no studies to date have systematically evaluated its role in the differentiation of healthy myocardium from diffuse disease in a clinical setting. METHODS: Consecutive subjects undergoing routine clinical cardiac magnetic resonance at King's College London were invited to participate in this study. Groups were based on cardiac magnetic resonance findings and consisted of subjects with known hypertrophic cardiomyopathy (n = 25) and nonischemic dilated cardiomyopathy (n = 27). Thirty normotensive subjects with low pre-test likelihood of cardiomyopathy, not taking any regular medications and with normal cardiac magnetic resonance findings including normal left ventricular mass indexes, served as controls. Single equatorial short-axis slice T1 mapping was performed using a 3-T scanner before and at 10, 20, and 30 minutes after the administration of 0.2 mmol/kg of gadobutrol. T1 values were quantified within the septal myocardium (T1native), and extracellular volume fractions (ECV) were calculated. RESULTS: T1native was significantly longer in patients with cardiomyopathy compared with control subjects (p < 0.01). Conversely, post-contrast T1 values were significantly shorter in patients with cardiomyopathy at all time points (p < 0.01). ECV was significantly higher in patients with cardiomyopathy compared with controls at all time points (p < 0.01). Multivariate binary logistic regression revealed that T1native could differentiate between healthy and diseased myocardium with sensitivity of 100%, specificity of 96%, and diagnostic accuracy of 98% (area under the curve 0.99; 95% confidence interval: 0.96 to 1.00; p < 0.001), whereas post-contrast T1 values and ECV showed lower discriminatory performance. CONCLUSIONS: This study demonstrates that native and post-contrast T1 values provide indexes with high diagnostic accuracy for the discrimination of normal and diffusely diseased myocardium.

Download full-text


Available from: Valentina Puntmann, Oct 08, 2015
29 Reads
    • "Furthermore, choice of a less stringent method of LGE calculation such as 4–5 SD above the signal of the remote myocardium and therefore increase of the calculated relative fibrosis size, which was suggested to best correlate with fibrosis found in histopathologic specimens, did not lead to improvement of correlation (data not shown) [20]. Previous studies in patients with HCM demonstrated that T1 relaxation times are significantly higher both in the hypertrophied segments and in the remote myocardium in comparison to healthy volunteers, however no thresholds for calculation of fibrosis were proposed [21] [22] [23]. Increase of native T1 values in patients with HCM in comparison to controls was observed both in segments with and without LGE, but T1 values in segments with LGE were significantly higher than those measured in segments without LGE [23]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Myocardial fibrosis was shown to influence prognosis in hypertrophic cardiomyopathy (HCM). It is typically assessed by late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR). Native T1-mapping has been proposed, as a contrast-free method of fibrosis assessment. The aim of the study was to define a cut-off value for native T1 relaxation time that best reflects LGE quantification of myocardial fibrosis. In 25 patients with HCM and 20 controls we performed T1-mapping pre-contrast using ShMOLLI technique. This was followed by LGE assessment in the studied group 10 minutes after gadolinium contrast injection. Relative myocardial fibrosis size was calculated for varying T1 time thresholds (940-1100 ms) and compared with 6SD method for LGE. Median fibrosis size calculated with T1-mapping was insignificantly different from LGE only for native T1 time threshold of 1060 ms (p=0.62). Using this threshold, Bland-Altman plots demonstrated very good agreement between fibrosis sizes from the two methods (slightly better only for 1080 ms threshold). For threshold of 1060 ms we also observed good correlation (rho=0.73) with LGE 6SD method (insignificantly better for lower thresholds, best for threshold of 980 ms - rho=0.88). In control group with no diagnosis of HCM, fibrosis size <1% was reached for thresholds of 1040 ms and higher. Native T1-mapping can be used for non-contrast assessment of myocardial fibrosis in HCM. The 1060 ms threshold of the native T1 relaxation time is characterized by the best balance between agreement and correlation with fibrosis assessed by LGE 6 SD method. Copyright © 2015. Published by Elsevier Inc.
    Magnetic Resonance Imaging 04/2015; 33(6). DOI:10.1016/j.mri.2015.04.001 · 2.09 Impact Factor
  • Source
    • "The Modified Look-Locker Inversion Recovery (MOLLI) has been proposed for measuring cardiac T1 during a single breath-hold [6], [16]–[18] and has been used to calculate λ in some reported studies [4], [11], [12], [15]. However, previously proposed MOLLI protocols have mostly been derived using 1.5-Tesla MR systems [19]–[21]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Our purpose was to validate an early enhancement time point for accurately measuring the myocardial contrast partition coefficient (lambda) using dynamic-equilibrium magnetic resonance imaging. The pre- and post-contrast longitudinal relaxation rates (reciprocal of T1) of the interventricular septum (R1m) and blood pool (R1b) were obtained from fifteen healthy volunteers and three diabetic patients with hypertension using two optimized T1 mapping sequences (modified Look-Locker inversion recovery) on a 3-Tesla magnetic resonance scanner. Reference lambda values were calculated as the slope of the regression line of R1m versus R1b at dynamic equilibrium (multi-point regression method). The simplified pre-/post-enhancement two-acquisition method (two-point method) was used to calculate lambda by relating the change in R1m and R1b using different protocols according to the acquisition stage of the post-enhancement data point. The agreement with the referential method was tested by calculating Pearson's correlation coefficient and the intra-class correlation coefficient. The lambda values measured by the two-point method increased (from 0.479±0.041 to 0.534±0.043) over time from 6 to 45 minutes after contrast and exhibited good correlation with the reference at each time point (r≥0.875, p<0.05). The intra-class correlation coefficient on absolute agreement with the reference lambda was 0.946, 0.929 and 0.922 at the 6th, 7th and 8th minutes and dropped from 0.878 to 0.403 from the 9th minute on. The time-efficient two-point method at 6-8 minutes after the Gd-DTPA bolus injection exhibited good agreement with the multi-point regression method and can be applied for accurate lambda measurement in normal myocardium.
    PLoS ONE 03/2014; 9(3):e93124. DOI:10.1371/journal.pone.0093124 · 3.23 Impact Factor
  • Source
    • "Little biopsy histological correlation is available in these diseases however. Native T1 mapping has also been used for identification of diffuse myocardial fibrosis in aortic stenosis and non-ischaemic cardiomyopathies [61, 62], as well as the detection of acute myocarditis and showed excellent and superior diagnostic performance compared with T2-weighted CMR [63]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cardiovascular magnetic resonance imaging (CMR) has become the gold standard not only for cardiac volume and function quantification, but for a key unique strength: non-invasive myocardial tissue characterization. Several different techniques, separately or in combination, can detect and quantify early and established myocardial pathological processes permitting better diagnosis, prognostication and tracking of therapy. The authors will focus on the histological and pathophysiological evidence of these imaging parameters in the characterization of edema, infarction, scar and fibrosis. In addition to laying out the strengths and weaknesses of each modality, the reader will be introduced to rapid developments in T1 and T2 mapping as well as the use of contrast-derived extracellular volume for quantification of diffuse fibrosis.
    Current Cardiovascular Imaging Reports 03/2014; 7(3). DOI:10.1007/s12410-013-9254-9
Show more